Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-039719
Filing Date
2020-08-12
Accepted
2020-08-12 16:43:22
Documents
60
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q idya-10q_20200630.htm 10-Q 2714592
2 EX-10.3 idya-ex103_470.htm EX-10.3 1142511
3 EX-31.1 idya-ex311_7.htm EX-31.1 18186
4 EX-31.2 idya-ex312_10.htm EX-31.2 18219
5 EX-32.1 idya-ex321_6.htm EX-32.1 12379
6 GRAPHIC gguizd4shtq0000001.jpg GRAPHIC 2160
  Complete submission text file 0001564590-20-039719.txt   8314704

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT idya-20200630.xml EX-101.INS 1271529
8 XBRL TAXONOMY EXTENSION SCHEMA idya-20200630.xsd EX-101.SCH 48349
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE idya-20200630_cal.xml EX-101.CAL 37714
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE idya-20200630_def.xml EX-101.DEF 162260
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE idya-20200630_lab.xml EX-101.LAB 391520
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idya-20200630_pre.xml EX-101.PRE 291472
Mailing Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Filer) CIK: 0001676725 (see all company filings)

EIN.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38915 | Film No.: 201095951
SIC: 2834 Pharmaceutical Preparations